DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) Fundamental Analysis & Valuation

NASDAQ:DHCNL • US25525P3055

18.6 USD
+0.29 (+1.58%)
Last: Mar 4, 2026, 08:20 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This DHCNL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

DHCNL gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 122 industry peers in the Diversified REITs industry. DHCNL has a bad profitability rating. Also its financial health evaluation is rather negative. DHCNL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. DHCNL Profitability Analysis

1.1 Basic Checks

  • DHCNL had negative earnings in the past year.
  • In the past year DHCNL has reported a negative cash flow from operations.
  • DHCNL had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: DHCNL reported negative operating cash flow in multiple years.
DHCNL Yearly Net Income VS EBIT VS OCF VS FCFDHCNL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M

1.2 Ratios

  • With a Return On Assets value of -6.56%, DHCNL is not doing good in the industry: 86.89% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of -17.16%, DHCNL is doing worse than 82.79% of the companies in the same industry.
Industry RankSector Rank
ROA -6.56%
ROE -17.16%
ROIC N/A
ROA(3y)-6.38%
ROA(5y)-3.36%
ROE(3y)-16.21%
ROE(5y)-8.53%
ROIC(3y)N/A
ROIC(5y)N/A
DHCNL Yearly ROA, ROE, ROICDHCNL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 -10 -15

1.3 Margins

  • DHCNL has a Gross Margin of 18.11%. This is amonst the worse of the industry: DHCNL underperforms 94.26% of its industry peers.
  • In the last couple of years the Gross Margin of DHCNL has declined.
  • The Profit Margin and Operating Margin are not available for DHCNL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.03%
GM growth 5Y-5.67%
DHCNL Yearly Profit, Operating, Gross MarginsDHCNL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. DHCNL Health Analysis

2.1 Basic Checks

  • DHCNL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DHCNL has been increased compared to 1 year ago.
  • DHCNL has more shares outstanding than it did 5 years ago.
  • DHCNL has a better debt/assets ratio than last year.
DHCNL Yearly Shares OutstandingDHCNL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
DHCNL Yearly Total Debt VS Total AssetsDHCNL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • DHCNL has an Altman-Z score of 0.38. This is a bad value and indicates that DHCNL is not financially healthy and even has some risk of bankruptcy.
  • DHCNL's Altman-Z score of 0.38 is in line compared to the rest of the industry. DHCNL outperforms 42.62% of its industry peers.
  • A Debt/Equity ratio of 1.44 is on the high side and indicates that DHCNL has dependencies on debt financing.
  • The Debt to Equity ratio of DHCNL (1.44) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF N/A
Altman-Z 0.38
ROIC/WACCN/A
WACC8.47%
DHCNL Yearly LT Debt VS Equity VS FCFDHCNL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • DHCNL has a Current Ratio of 1.56. This is a normal value and indicates that DHCNL is financially healthy and should not expect problems in meeting its short term obligations.
  • DHCNL has a better Current ratio (1.56) than 79.51% of its industry peers.
  • DHCNL has a Quick Ratio of 1.56. This is a normal value and indicates that DHCNL is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.56, DHCNL belongs to the top of the industry, outperforming 80.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.56
DHCNL Yearly Current Assets VS Current LiabilitesDHCNL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. DHCNL Growth Analysis

3.1 Past

  • DHCNL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.76%.
  • Looking at the last year, DHCNL shows a small growth in Revenue. The Revenue has grown by 2.84% in the last year.
  • DHCNL shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.18% yearly.
EPS 1Y (TTM)-4.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)2.84%
Revenue growth 3Y6.21%
Revenue growth 5Y-1.18%
Sales Q2Q%-0.01%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.95% on average over the next years. This is a very strong growth
  • DHCNL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.03% yearly.
EPS Next Y49.5%
EPS Next 2Y23.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.55%
Revenue Next 2Y4.03%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DHCNL Yearly Revenue VS EstimatesDHCNL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
DHCNL Yearly EPS VS EstimatesDHCNL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. DHCNL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DHCNL. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DHCNL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DHCNL Price Earnings VS Forward Price EarningsDHCNL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

  • DHCNL's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. DHCNL is more expensive than 91.80% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.88
DHCNL Per share dataDHCNL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • DHCNL's earnings are expected to grow with 23.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.95%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. DHCNL Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.55%, DHCNL is not a good candidate for dividend investing.
  • With a Dividend Yield of 0.55, DHCNL pays less dividend than the industry average, which is at 7.07. 91.80% of the companies listed in the same industry pay a better dividend than DHCNL!
  • Compared to an average S&P500 Dividend Yield of 1.82, DHCNL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.55%

5.2 History

  • The dividend of DHCNL decreases each year by -25.96%.
  • DHCNL has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-25.96%
Div Incr Years0
Div Non Decr Years0
DHCNL Yearly Dividends per shareDHCNL Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • The earnings of DHCNL are negative and hence is the payout ratio. DHCNL will probably not be able to sustain this dividend level.
DP-3.38%
EPS Next 2Y23.95%
EPS Next 3YN/A
DHCNL Yearly Income VS Free CF VS DividendDHCNL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

More info and screens

Find the best dividend stocksShow peers with best dividend

DHCNL Fundamentals: All Metrics, Ratios and Statistics

DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46

NASDAQ:DHCNL (3/4/2026, 8:20:03 PM)

18.6

+0.29 (+1.58%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-23
Earnings (Next)05-04
Inst Owners76.96%
Inst Owner ChangeN/A
Ins Owners0.48%
Ins Owner ChangeN/A
Market Cap4.50B
Revenue(TTM)1.54B
Net Income(TTM)-285.89M
Analysts74.29
Price Target17.2 (-7.53%)
Short Float %0.02%
Short Ratio2.42
Dividend
Industry RankSector Rank
Dividend Yield 0.55%
Yearly Dividend0.04
Dividend Growth(5Y)-25.96%
DP-3.38%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-82.03%
Min EPS beat(2)-213.15%
Max EPS beat(2)49.08%
EPS beat(4)2
Avg EPS beat(4)-28.15%
Min EPS beat(4)-213.15%
Max EPS beat(4)122.5%
EPS beat(8)3
Avg EPS beat(8)-9.87%
EPS beat(12)5
Avg EPS beat(12)-4.94%
EPS beat(16)5
Avg EPS beat(16)-13.8%
Revenue beat(2)1
Avg Revenue beat(2)-1.84%
Min Revenue beat(2)-4.35%
Max Revenue beat(2)0.67%
Revenue beat(4)1
Avg Revenue beat(4)-1.05%
Min Revenue beat(4)-4.35%
Max Revenue beat(4)0.67%
Revenue beat(8)2
Avg Revenue beat(8)-0.93%
Revenue beat(12)4
Avg Revenue beat(12)-0.74%
Revenue beat(16)5
Avg Revenue beat(16)-0.93%
PT rev (1m)-11.51%
PT rev (3m)-16.2%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.89%
EPS NY rev (1m)0%
EPS NY rev (3m)-54.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.93
P/FCF N/A
P/OCF N/A
P/B 2.7
P/tB 2.7
EV/EBITDA 28.88
EPS(TTM)-1.1
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)-0.69
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS6.35
BVpS6.88
TBVpS6.88
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.56%
ROE -17.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.11%
FCFM N/A
ROA(3y)-6.38%
ROA(5y)-3.36%
ROE(3y)-16.21%
ROE(5y)-8.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.03%
GM growth 5Y-5.67%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF N/A
Debt/EBITDA 10.3
Cap/Depr 56.06%
Cap/Sales 9.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 1.56
Altman-Z 0.38
F-Score6
WACC8.47%
ROIC/WACCN/A
Cap/Depr(3y)69.85%
Cap/Depr(5y)90%
Cap/Sales(3y)13.23%
Cap/Sales(5y)17.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y49.5%
EPS Next 2Y23.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.84%
Revenue growth 3Y6.21%
Revenue growth 5Y-1.18%
Sales Q2Q%-0.01%
Revenue Next Year2.55%
Revenue Next 2Y4.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y45.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1793.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-86.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.48%
OCF growth 3YN/A
OCF growth 5YN/A

DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 / DHCNL FAQ

What is the ChartMill fundamental rating of DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) stock?

ChartMill assigns a fundamental rating of 2 / 10 to DHCNL.


What is the valuation status of DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) stock?

ChartMill assigns a valuation rating of 1 / 10 to DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL). This can be considered as Overvalued.


How profitable is DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) stock?

DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) has a profitability rating of 0 / 10.


What is the earnings growth outlook for DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46?

The Earnings per Share (EPS) of DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) is expected to grow by 49.5% in the next year.


How sustainable is the dividend of DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) stock?

The dividend rating of DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) is 1 / 10 and the dividend payout ratio is -3.38%.